Immunotherapy is a promising and evolving treatment for cancer that helps harness the body’s own immune system to target and kill cancer cells. However, not everyone responds to treatment and some immunotherapies are associated with severe side effects.

SalubrisBio is currently developing a potential treatment to make immunotherapies more effective and less toxic. Check back for updates on our first oncology clinical trial planned for 2022.